SCHEMBL30937575

SCHEMBL30937575

C[C@H](NC(=O)CN1Cc2nc(C(F)(F)F)ccc2NC1=O)c1ccc(F)cc1F

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ GPR139 Q6DWJ6 13/20 0.43
▸ MAPK1 P28482 1/20 0.40
▸ PDE2A O00408 3/20 0.37
▸ TRPV1 Q8NER1 1/20 0.35
▸ KCNK3 O14649 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937644 0.88 GPR139 (0.45) GPR139MAPK1
SCHEMBL30937581 0.88 GPR139 (0.45) GPR139MAPK1
SCHEMBL30937648 0.85 GPR139 (0.43) GPR139MAPK1KCNK3
SCHEMBL30937645 0.82 GPR139 (0.47) GPR139MAPK1
SCHEMBL30937611 0.79 ACE (0.47) GPR139MAPK1
SCHEMBL30937726 0.78 GPR139 (0.48) GPR139MAPK1
SCHEMBL30937598 0.77 GPR139 (0.45) GPR139MAPK1
SCHEMBL30937710 0.77 MAPK1 (0.47) GPR139MAPK1
SCHEMBL31120559 0.75 GPR139 (0.47) GPR139
SCHEMBL30937745 0.74 TRPV1 (0.35) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback